The major benefits of DAAs in the pediatric population include:
1. High Efficacy: DAAs have demonstrated cure rates exceeding 90%, which is significantly higher than previous treatments. 2. Shorter Treatment Duration: Treatment courses are typically 8 to 12 weeks, compared to up to a year with older therapies. 3. Minimal Side Effects: DAAs generally have a better side effect profile, which is particularly important for children. 4. Improved Quality of Life: Effective treatment with fewer side effects means children can maintain their normal activities and development without significant disruption.
